|
ES2641897T3
(es)
*
|
2007-01-05 |
2017-11-14 |
University Of Zurich |
Procedimiento para proporcionar moléculas de unión y diana específicas de una enfermedad
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
CA2702880A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Immunas Pharma, Inc. |
Antibody capable of specifically binding to a beta oligomer, and use thereof
|
|
PL2246427T3
(pl)
|
2008-02-08 |
2017-06-30 |
Immunas Pharma, Inc. |
Przeciwciała zdolne do wiązania się swoiście do oligomerów amyloidu beta i ich stosowanie
|
|
CA2730073A1
(en)
*
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
EP2949666B1
(en)
|
2008-12-19 |
2018-12-19 |
Biogen International Neuroscience GmbH |
Human anti-alpha-synuclein antibodies
|
|
EP2419447B1
(en)
|
2009-04-17 |
2017-08-23 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
JP5599454B2
(ja)
|
2009-08-06 |
2014-10-01 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
EP3196212B1
(en)
|
2010-02-24 |
2020-06-03 |
ImmunoGen, Inc. |
Immunoconjugates comprising a folate receptor 1 antibody
|
|
US20150018408A1
(en)
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
CN103547288B
(zh)
|
2011-01-10 |
2016-03-16 |
密执安大学评议会 |
干细胞因子抑制剂
|
|
ES2634098T3
(es)
|
2011-01-14 |
2017-09-26 |
The Regents Of The University Of California |
Anticuerpos terapéuticos contra la proteína ROR-1 y procedimientos para el uso de los mismos.
|
|
UA113403C2
(xx)
|
2011-04-01 |
2017-01-25 |
|
Спосіб підвищення ефективності folr1 терапії раку
|
|
LT2723379T
(lt)
|
2011-06-23 |
2018-10-25 |
Biogen International Neuroscience Gmbh |
Anti-alfa sinukleiną rišančios molekulės
|
|
GB201110938D0
(en)
*
|
2011-06-27 |
2011-08-10 |
Iti Scotland Ltd |
Compounds
|
|
EP2756002A4
(en)
*
|
2011-09-16 |
2015-04-08 |
Univ Texas |
COMPOSITIONS AND METHODS RELATED TO THE REPAIR OF DNA DAMAGES
|
|
SMT202000158T1
(it)
*
|
2012-08-31 |
2020-05-08 |
Immunogen Inc |
Saggi e kit diagnostici per il rilevamento del recettore dei folati 1
|
|
CA2894879A1
(en)
*
|
2012-12-19 |
2014-06-26 |
Amplimmune, Inc. |
B7-h4 specific antibodies, and compositions and methods of use thereof
|
|
US9534044B2
(en)
*
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
|
AU2014308699C1
(en)
*
|
2013-08-21 |
2022-06-02 |
Board Of Regents, The University Of Texas System |
Compositions and methods for targeting connexin hemichannels
|
|
CA2921975C
(en)
|
2013-08-30 |
2024-02-13 |
Immunogen, Inc. |
Antibodies and assays for detection of folate receptor 1
|
|
EP3054974A4
(en)
*
|
2013-10-10 |
2017-06-14 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US9416197B2
(en)
|
2013-11-01 |
2016-08-16 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease
|
|
AU2015213735A1
(en)
*
|
2014-02-10 |
2016-08-04 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human Tau and assay for quantifying human Tau using the antibodies
|
|
WO2015143277A1
(en)
*
|
2014-03-20 |
2015-09-24 |
Wellstat Diagnostics, Llc |
Antibodies and methods for the detection of cell death
|
|
SG11201607258SA
(en)
*
|
2014-04-10 |
2016-10-28 |
Obi Pharma Inc |
Antibodies, pharmaceutical compositions and uses thereof
|
|
WO2016028656A1
(en)
|
2014-08-19 |
2016-02-25 |
Merck Sharp & Dohme Corp. |
Anti-tigit antibodies
|
|
CA2959179A1
(en)
|
2014-09-16 |
2016-03-24 |
Ovascience, Inc. |
Anti-vasa antibodies, and methods of production and use thereof
|
|
US9732148B2
(en)
*
|
2014-10-16 |
2017-08-15 |
Genentech, Inc. |
Anti-α-synuclein antibodies and methods of use
|
|
EP3218005B1
(en)
|
2014-11-12 |
2023-01-04 |
Seagen Inc. |
Glycan-interacting compounds and methods of use
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
JP6827928B2
(ja)
*
|
2014-12-19 |
2021-02-10 |
ユニヴェルシテ・ドゥ・ナント |
抗ｉｌ−３４抗体
|
|
AU2016210835B2
(en)
*
|
2015-01-29 |
2021-01-21 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
CA2977646A1
(en)
*
|
2015-02-24 |
2016-09-01 |
Rpeptide, Llc |
Anti-amyloid-beta antibodies
|
|
WO2016145022A1
(en)
|
2015-03-11 |
2016-09-15 |
The Board Of Regents Of The University Of Texas System |
Anti-dc-hil antibodies for cancer diagnosis, prognosis and therapy
|
|
WO2016149116A1
(en)
*
|
2015-03-13 |
2016-09-22 |
University Of Maryland, Baltimore |
Antibodies targeting s100b and methods of use
|
|
CN107530427A
(zh)
*
|
2015-03-27 |
2018-01-02 |
南加利福尼亚大学 |
针对用于实体肿瘤的治疗的lhr的car t细胞疗法
|
|
EP3307784B1
(en)
*
|
2015-06-10 |
2021-12-22 |
National Research Council of Canada |
Carbonic anhydrase ix-specific antibodies and uses thereof
|
|
WO2016205566A1
(en)
*
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
CN108290936B
(zh)
|
2015-08-14 |
2022-07-12 |
默沙东公司 |
抗tigit抗体
|
|
KR20250073532A
(ko)
|
2015-09-02 |
2025-05-27 |
이뮤텝 에스.에이.에스. |
항-lag-3 항체
|
|
US10172875B2
(en)
|
2015-09-17 |
2019-01-08 |
Immunogen, Inc. |
Therapeutic combinations comprising anti-FOLR1 immunoconjugates
|
|
CA3004494A1
(en)
|
2015-11-09 |
2017-05-18 |
The University Of British Columiba |
Epitopes in amyloid beta mid-region and conformationally-selective antibodies thereto
|
|
KR20180094876A
(ko)
|
2015-11-09 |
2018-08-24 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타 에피토프 및 이에 대한 항체
|
|
CN108350051A
(zh)
|
2015-11-09 |
2018-07-31 |
英属哥伦比亚大学 |
淀粉样蛋白β中的N-末端表位及其构象选择性抗体
|
|
HK1253049A1
(zh)
|
2015-11-12 |
2019-06-06 |
Seagen Inc. |
糖基相互作用化合物及其使用方法
|
|
JP7109382B2
(ja)
|
2016-03-04 |
2022-07-29 |
ジェイエヌ バイオサイエンシーズ エルエルシー |
Ｔｉｇｉｔに対する抗体
|
|
CN115010808A
(zh)
*
|
2016-03-16 |
2022-09-06 |
阿贝奥姆公司 |
针对il-25的中和单克隆抗体及其用途
|
|
US20180362660A1
(en)
*
|
2016-05-09 |
2018-12-20 |
Schickwann Tsai |
Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
|
|
JP2019517813A
(ja)
*
|
2016-06-16 |
2019-06-27 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
Ｃｄ８１に対するヒト化及びキメラモノクローナル抗体
|
|
CA3031135A1
(en)
*
|
2016-07-18 |
2018-01-25 |
The University Of British Columbia |
Antibodies to amyloid beta
|
|
JOP20170154B1
(ar)
*
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
US11401330B2
(en)
|
2016-11-17 |
2022-08-02 |
Seagen Inc. |
Glycan-interacting compounds and methods of use
|
|
CN108367075B
(zh)
|
2016-11-23 |
2022-08-09 |
免疫方舟医药技术股份有限公司 |
4-1bb结合蛋白及其用途
|
|
CN106749657A
(zh)
*
|
2016-12-13 |
2017-05-31 |
中国农业科学院哈尔滨兽医研究所 |
一种抗体信号肽及其应用
|
|
WO2018156434A1
(en)
*
|
2017-02-22 |
2018-08-30 |
H. Lee Moffitt Cancer Center And Research Institute Inc. |
Tim3-binding chimeric antigen receptors
|
|
US11274160B2
(en)
*
|
2017-03-02 |
2022-03-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to Nectin-4 and uses thereof
|
|
KR102653141B1
(ko)
|
2017-03-03 |
2024-04-01 |
씨젠 인크. |
글리칸-상호작용 화합물 및 사용 방법
|
|
JP7305549B2
(ja)
*
|
2017-04-05 |
2023-07-10 |
エックスディーシーエクスプローラー （シャンハイ） カンパニー リミテッド |
ヒト化抗ｔｐｂｇ抗体およびその製造方法、その複合体および使用
|
|
KR102869563B1
(ko)
|
2017-07-17 |
2025-10-10 |
얀센 바이오테크 인코포레이티드 |
피브로넥틴 iii형 도메인에 대한 항원 결합 영역 및 이의 사용 방법
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
WO2019023247A1
(en)
|
2017-07-25 |
2019-01-31 |
Immutics, Inc. |
TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
|
|
LT3672631T
(lt)
|
2017-08-22 |
2023-04-25 |
Biogen Ma Inc. |
Farmacinės kompozicijos, kurių sudėtyje yra antikūnų prieš beta amiloidą
|
|
TW202003576A
(zh)
*
|
2018-05-10 |
2020-01-16 |
美商艾博視訊有限公司 |
活化cd40之單株抗體及其用途
|
|
JP7210612B2
(ja)
*
|
2018-05-30 |
2023-01-23 |
ナショナル ヘルス リサーチ インスティチューツ |
抗ａベータ抗体及びその使用
|
|
AU2019287720B2
(en)
*
|
2018-06-14 |
2025-08-28 |
Regeneron Pharmaceuticals, Inc. |
CD79A chimeric antigen receptors
|
|
WO2020016661A2
(en)
*
|
2018-07-09 |
2020-01-23 |
Multitude Inc. |
Antibodies specific to folate receptor alpha
|
|
IL281594B1
(en)
|
2018-09-17 |
2025-10-01 |
Abcuro Inc |
Antibodies against KLRG1
|
|
US12448446B2
(en)
*
|
2019-01-29 |
2025-10-21 |
Shanghai Jiao Tong University |
Chimeric antigen receptor and use thereof
|
|
AU2020214796A1
(en)
|
2019-01-30 |
2021-07-29 |
Truebinding, Inc. |
Anti-Gal3 antibodies and uses thereof
|
|
WO2020180706A1
(en)
*
|
2019-03-02 |
2020-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic antigen binding proteins specific for cd93 and methods of use thereof
|
|
JOP20210265A1
(ar)
|
2019-03-26 |
2023-01-30 |
Janssen Pharmaceutica Nv |
الأجسام المضادة لبيروغلوتامات أميلويد بيتا واستخداماتها
|
|
CN110343180B
(zh)
*
|
2019-07-25 |
2021-03-30 |
北京免疫方舟医药科技有限公司 |
抗ctla-4抗体及其应用
|
|
US12352719B2
(en)
|
2019-09-20 |
2025-07-08 |
KYCERA AVX Components Corporation |
Somatic cell-based electrical biosensor
|
|
CN111808191A
(zh)
*
|
2020-05-11 |
2020-10-23 |
廊坊天光生物技术有限公司 |
一种用于检测血清中vegf含量的抗体对及其用途
|
|
CN111793136A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种nmp22抗体对及其应用
|
|
US20230340089A1
(en)
*
|
2020-05-14 |
2023-10-26 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
US12281166B2
(en)
|
2020-05-26 |
2025-04-22 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking Galectin-3
|
|
PE20231078A1
(es)
|
2020-06-02 |
2023-07-17 |
Arcus Biosciences Inc |
Anticuerpos anti-tigit
|
|
WO2021262791A1
(en)
|
2020-06-25 |
2021-12-30 |
Merck Sharp & Dohme Corp. |
High affinity antibodies targeting tau phosphorylated at serine 413
|
|
KR20230039734A
(ko)
|
2020-07-23 |
2023-03-21 |
오타이르 프로테나 리미티드 |
항-Aβ 항체
|
|
JP2023536629A
(ja)
*
|
2020-08-04 |
2023-08-28 |
エグゼリクシス， インコーポレイテッド |
Ｃｄ４７結合性作用剤およびその使用
|
|
JP7634082B2
(ja)
|
2020-08-18 |
2025-02-20 |
オメロス コーポレーション |
補体因子ｄを検出するためのモノクローナル抗体、組成物、および方法
|
|
CN112778419A
(zh)
*
|
2021-02-01 |
2021-05-11 |
重庆中元汇吉生物技术有限公司 |
抗ck-mb的抗体或其抗原结合部分及其应用
|
|
US20240117047A1
(en)
*
|
2021-02-11 |
2024-04-11 |
The Regents Of The University Of California |
Monoclonal antibodies specific for human ror1
|
|
CN113075398A
(zh)
*
|
2021-03-23 |
2021-07-06 |
中国医学科学院输血研究所 |
一种血浆中特异性IgG抗体的定量测定方法
|
|
US20250180551A1
(en)
*
|
2021-10-26 |
2025-06-05 |
Bach Diagnostics Inc. |
Lateral flow assay for the diagnosis of dermatomycosis
|
|
JP2025537193A
(ja)
*
|
2022-11-08 |
2025-11-14 |
フェインズ セラピューティクス，インコーポレーテッド |
抗５ｔ４抗体及びその使用
|
|
US20240247077A1
(en)
*
|
2023-01-23 |
2024-07-25 |
Clemson University Research Foundation |
Cyp1a1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
US20240352102A1
(en)
*
|
2023-01-27 |
2024-10-24 |
The United States Government As Represented By The Department Of Veterans Affairs |
Compositions for treating tauopathies and methods of use thereof
|
|
IL322621A
(en)
*
|
2023-02-28 |
2025-10-01 |
Mayo Found Medical Education & Res |
Molecules that bind to B-cell activating factor receptor polypeptides
|
|
CN119306826B
(zh)
*
|
2023-07-11 |
2025-06-20 |
东莞市朋志生物科技有限公司 |
抗白介素-6抗体、检测白介素-6的试剂和试剂盒
|
|
WO2025044931A1
(zh)
*
|
2023-08-25 |
2025-03-06 |
康诺亚生物医药科技（成都）有限公司 |
阿尔茨海默病治疗剂的开发和应用
|
|
CN119613538B
(zh)
*
|
2024-12-12 |
2025-10-17 |
浙江大学医学院附属第一医院(浙江省第一医院) |
抗h10亚型流感病毒血凝素蛋白中和性单克隆抗体1e10及其应用
|
|
CN120209138B
(zh)
*
|
2025-05-29 |
2025-10-03 |
杭州广科安德生物科技有限公司 |
Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用
|